- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRNA
Recent news which mentions MRNA
5 Top Stocks to Buy in March
March 03, 2024
From Motley Fool
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
From Motley Fool
Got $200? 2 Dividend Stocks to Buy and Hold Forever
March 01, 2024
From Motley Fool
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
February 29, 2024
From Motley Fool
From Benzinga
Earnings Seasons Score Card: 4 Stock Superstars and 3 That Fell Short
February 28, 2024
From InvestorPlace
From Benzinga
Moderna Stock Has 33% Upside, According to 1 Wall Street Analyst
February 28, 2024
Tickers
MRNA
From Motley Fool
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
From Benzinga
From Benzinga
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
From Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
February 22, 2024
From Benzinga
Moderna Posts Quarterly Profit Despite Lower Sales From COVID-19 Vaccine
February 22, 2024
From Benzinga
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
February 22, 2024
From Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
From Benzinga
Moderna Likely To Report Q4 Loss; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 22, 2024
From Benzinga
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
From Benzinga
Looming Layoffs? 3 Companies That May Be the Next to Drop the Axe.
February 19, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
From Benzinga
To Sell or Not to Sell: How to Handle the Inevitable Nvidia Downturn
February 15, 2024
From InvestorPlace
Moderna's Options: A Look at What the Big Money is Thinking
February 14, 2024
Tickers
MRNA
From Benzinga
From InvestorPlace
2 Stocks Down 36% or More to Buy and Hold for 10 Years
February 13, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.